Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

25%(1 trials)

Phase Distribution

Ph phase_1

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 1Safety & dosage

7(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Terminated(3)

Detailed Status

Completed4

Withdrawn3

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 17 (100.0%)

Trials by Status

completed457%

withdrawn343%

Recent Activity

0 active trials

Showing 5 of 7

completedphase_1

Assessment of Varying Oral Dosing Regimens for F901318 in Healthy Subjects

NCT03340597

withdrawnphase_1

Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients

NCT02856178

withdrawnphase_1

Clinical Trials (7)

Showing 7 of 7 trials

NCT03340597Phase 1

Assessment of Varying Oral Dosing Regimens for F901318 in Healthy Subjects

Completed

NCT02856178Phase 1

Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients

Withdrawn

NCT03095547Phase 1

Drug/Drug Interactions With F901318

Withdrawn

NCT03076905Phase 1

Pharmacokinetics of IV Formulation

Withdrawn

NCT02730442Phase 1

Study of Potential for Interaction of Fluconazole With F901318

Completed

NCT02342574Phase 1

F901318 Multiple Ascending Dose Study

Completed

NCT02142153Phase 1

F901318 Single Ascending Dose Study in Healthy Male Volunteers

Completed

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7